( University of Maryland Medical Center ) Researchers at the University of Maryland School of Medicine have found that an approved drug for treating rheumatoid arthritis reduces severe illness and death in mice exposed to the Influenza A virus. Their findings, reported in The Journal of Immunology, suggest that tempering the response of the body’s immune system to influenza infection may …








